Elite Pharmaceuticals, Inc. Deferred Tax Liabilities, Intangible Assets
Elite Pharmaceuticals, Inc. (ELTP) had Deferred Tax Liabilities, Intangible Assets of $621.00 thousand as of 2026-03-31, per its 10-K filed 2026-06-29.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets · last filed 2026-06-29
- 2026-03-31: Deferred Tax Liabilities, Intangible Assets $621.00K.
- 2025-03-31: Deferred Tax Liabilities, Intangible Assets $711.00K.
- 2024-03-31: Deferred Tax Liabilities, Intangible Assets $1.03M.
| Period end | Deferred Tax Liabilities, Intangible Assets |
|---|---|
| 2026-03-31 | $621.00K 10-K · filed 2026-06-29 |
| 2025-03-31 | $711.00K 10-K · filed 2026-06-29 |
| 2024-03-31 | $1.03M 10-K · filed 2025-06-30 |